Literature DB >> 6716397

2-Substituted thiazolidine-4(R)-carboxylic acids as prodrugs of L-cysteine. Protection of mice against acetaminophen hepatotoxicity.

H T Nagasawa, D J Goon, W P Muldoon, R T Zera.   

Abstract

A number of 2-alkyl- and 2-aryl-substituted thiazolidine-4(R)-carboxylic acids were evaluated for their protective effect against hepatotoxic deaths produced in mice by LD90 doses of acetaminophen. 2(RS)-Methyl-, 2(RS)-n-propyl-, and 2(RS)-n- pentylthiazolidine -4(R)-carboxylic acids (compounds 1b,d,e, respectively) were nearly equipotent in their protective effect based on the number of surviving animals at 48 h as well as by histological criteria. 2(RS)-Ethyl-, 2(RS)-phenyl-, and 2(RS)-(4-pyridyl)thiazolidine-4(R)-carboxylic acids (compounds 1c,f,g) were less protective. The enantiomer of 1b, viz., 2(RS)- methylthiazolidine -4(S)-carboxylic acid (2b), was totally ineffective in this regard. Thiazolidine-4(R)-carboxylic acid (1a), but not its enantiomer, 2a, was a good substrate for a solubilized preparation of rat liver mitochondrial proline oxidase [Km = 1.1 x 10(-4) M; Vmax = 5.4 mumol min-1 (mg of protein)-1]. Compound 1b was not a substrate for proline oxidase but dissociated to L-cysteine in this system. At physiological pH and temperature, the hydrogens on the methyl group of 1b underwent deuterium exchange with solvent D2O (k1 = 2.5 X 10(-5) s), suggesting that opening of the thiazolidine ring must have taken place. Indeed, 1b labeled with 14C in the 2 and methyl positions was rapidly metabolized by the rat to produce 14CO2, 80% of the dose being excreted in this form in the expired air after 24 h. It is suggested that these 2-substituted thiazolidine-4(R)-carboxylic acids are prodrugs of L-cysteine that liberate this sulfhydryl amino acid in vivo by nonenzymatic ring opening, followed by solvolysis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6716397     DOI: 10.1021/jm00371a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Thorough study of reactivity of various compound classes toward the Folin-Ciocalteu reagent.

Authors:  Jace D Everette; Quinton M Bryant; Ashlee M Green; Yvonne A Abbey; Grant W Wangila; Richard B Walker
Journal:  J Agric Food Chem       Date:  2010-07-28       Impact factor: 5.279

2.  Novel, orally effective cyanide antidotes.

Authors:  Herbert T Nagasawa; David J W Goon; Daune L Crankshaw; Robert Vince; Steven E Patterson
Journal:  J Med Chem       Date:  2007-11-27       Impact factor: 7.446

3.  Modification of Acute and Chronic Liver Damage by Thiazolidine Compounds.

Authors:  András Divald; Zoltán Györgydeák; Ferenc Tímár; Attila Zalatnai; Rezsô Bognár; Gábor Horváth; Károly Lapis; András Jeney
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

4.  Glutathione-enhancing agents protect against steatohepatitis in a dietary model.

Authors:  Helieh S Oz; Hee-Jeong Im; Theresa S Chen; Willem J S de Villiers; Craig J McClain
Journal:  J Biochem Mol Toxicol       Date:  2006       Impact factor: 3.642

5.  Comparative efficacies of 2 cysteine prodrugs and a glutathione delivery agent in a colitis model.

Authors:  Helieh S Oz; Theresa S Chen; Herbert Nagasawa
Journal:  Transl Res       Date:  2007-05-23       Impact factor: 7.012

6.  Stereoisomers of cysteine and its analogs Potential effects on chemo- and radioprotection strategies.

Authors:  J C Roberts
Journal:  Amino Acids       Date:  1995-06       Impact factor: 3.520

7.  Development of S-Methylmethionine Sulfonium Derivatives and Their Skin-Protective Effect against Ultraviolet Exposure.

Authors:  Won-Serk Kim; Wang-Kyun Kim; Nahyun Choi; Wonhee Suh; Jinu Lee; Dae-Duk Kim; Ikyon Kim; Jong-Hyuk Sung
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

Review 8.  Prodrug approach for increasing cellular glutathione levels.

Authors:  Ivana Cacciatore; Catia Cornacchia; Francesco Pinnen; Adriano Mollica; Antonio Di Stefano
Journal:  Molecules       Date:  2010-03-03       Impact factor: 4.411

Review 9.  Application of prodrugs to inflammatory diseases of the gut.

Authors:  Helieh S Oz; Jeffrey L Ebersole
Journal:  Molecules       Date:  2008-02-27       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.